CV Sciences (CVSI) Share-based Compensation (2011 - 2026)
CV Sciences' (CVSI) quarterly Share-based Compensation came in at $148000.0 in Q1 2026, up 25.42% year-on-year from $118000.0 in Q1 2025, and up 20.33% quarter-over-quarter from $123000.0 in Q4 2025.
CV Sciences (CVSI) Share-based Compensation (2011 - 2026) Analysis & Trends
CV Sciences has disclosed Share-based Compensation across 14 years of filings, most recently posting $148000.0 for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $148000.0, up 25.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $527000.0 (up 52.31% YoY), and the FY2025 annual result was $497000.0, up 92.64% from the prior year.
- Share-based Compensation came in at $148000.0 for Q1 2026 at CV Sciences, up from $123000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $516000.0 in Q1 2022 to a low of $30000.0 in Q1 2024.
- The 5-year median for Share-based Compensation is $118000.0 (2023), against an average of $125294.1.
- Across the five-year window, Share-based Compensation plunged 83.99% in 2022 and soared 293.33% in 2025, its largest moves.
- CV Sciences' Share-based Compensation stood at $170000.0 in 2022, then slumped by 80.59% to $33000.0 in 2023, then jumped by 215.15% to $104000.0 in 2024, then gained by 18.27% to $123000.0 in 2025, then advanced by 20.33% to $148000.0 in 2026.
- The last three Share-based Compensation figures came in at $148000.0 (Q1 2026), $123000.0 (Q4 2025), and $124000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 148,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148,000.00 |
| Mar 31, 2026 | 148,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Dec 31, 2025 | 123,000.00 |
| Sep 30, 2025 | 124,000.00 |
| Sep 30, 2025 | 124,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 37,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |